1.Alternative Name:MOX1,MOX2,MRC,OX-2
2.Target:CD200
3.Source:Human CD200 was expressed from HEK293 with poly His at the C-terminal
4.Sequence:Gln31-Gly232
5.Protein structure:P41217His
6.Molecular Characterization:The protein has a calculated MW of 23kDa.The reducing (R) heterodimer protein migrates as 35-70 kDa due to glycosylation
7.Purity:SDS-PAGE>95%，SEC>95%
8.Reconstitution:sterile H2O
9.Endotoxin:<1EU/mg
10.Formulation:Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
Note:For research use only .


11.SDS-PAGE

Determined by SDS-PAGE, the purity of the protein is greater than 90%.

12.SEC-HPLC

Determined by SEC-HPLC, the purity of the protein is greater than 95%.

13.ELISA

When Recombinant Human CD200/His Protein is immobilized at 2μg/mL (100 μL/well), the concentration of Anti-Human CD200(samalizumab) that produces 50% of the optimal binding response is approximately 11 ng/ml.